Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4
Fangfang Zha1, Xiaolu Qu2, Bo Tang1
1Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Qingpu District, Shanghai 201700, P.R. China.
Abstract:
Long non-coding RNAs (lncRNAs) play vital roles in diabetic nephropathy (DN). This research aimed to study the potential role and underlying molecular mechanisms of long non-coding RNA MEG3 in DN. We found that MEG3 was upregulated in DN in vivo and in vitro and could enhance cell fibrosis and inflammatory response in DN. MEG3 functioned as an endogenous sponge for miR-181a in mesangial cells (MCs) via direct targeting and in an Ago2-dependent manner. MiR-181a inhibition promoted MC fibrosis and inflammatory response. In addition, Egr-1 was confirmed as a target gene of miR-181a. Further investigations verified that MEG3 promotes fibrosis and inflammatory response via the miR-181a/Egr-1/TLR4 axis in vitro and in vivo. These results provide new insights into the regulation between MEG3 and the miR-181a/Egr-1/TLR4 signaling pathway during DN progression.
Insights
Long non-coding RNA MEG3 exacerbates diabetic nephropathy (DN) by promoting fibrosis and inflammation. It acts as a sponge for miR-181a, regulating the Egr-1/TLR4 pathway in kidney cells.
Area of Science:
- Molecular Biology
- Genetics
- Nephrology
Background:
- Diabetic nephropathy (DN) is a severe complication of diabetes.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in DN pathogenesis.
- Understanding specific lncRNAs like MEG3 is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of long non-coding RNA MEG3 in diabetic nephropathy (DN).
- To elucidate the molecular mechanisms underlying MEG3's function in DN.
- To explore the interaction between MEG3, miR-181a, and the Egr-1/TLR4 signaling pathway.
Main Methods:
- In vivo and in vitro models of diabetic nephropathy.
- Quantitative real-time PCR to measure MEG3 and miR-181a expression.
- Western blotting to assess protein levels (Egr-1, TLR4).
- RNA immunoprecipitation assays to confirm Ago2-dependent interactions.
Main Results:
- MEG3 expression was significantly upregulated in DN models.
- MEG3 overexpression enhanced fibrosis and inflammatory responses in mesangial cells.
- MEG3 acted as an endogenous sponge for miR-181a, inhibiting its function.
- MiR-181a directly targeted Egr-1, and its inhibition promoted DN-related cellular changes.
- MEG3 promoted DN progression via the miR-181a/Egr-1/TLR4 signaling axis.
Conclusions:
- MEG3 plays a pro-fibrotic and pro-inflammatory role in diabetic nephropathy.
- The MEG3/miR-181a/Egr-1/TLR4 axis represents a novel regulatory pathway in DN.
- Targeting MEG3 or its downstream effectors may offer therapeutic strategies for DN.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Inflammatory Response I: Vascular and Cellular
lncRNA - Long Non-coding RNAs
The Eukaryotic Promoter Region
Hypothalamic-Pituitary Axis

